PURPOSE. Interleukin (IL)-18 has been described as a proinflammatory cytoki
ne in rheumatoid arthritis and bacterial infectious diseases. The present s
tudy was designed to determine the role of IL-18 in a model of ocular exper
imental autoimmune uveitis (EAU). The initial studies were conducted to det
ect the expression of IL-18 in normal mouse eye tissue, and the later studi
es investigated induction of EAU in mice with an IL-18(-/-) phenotype.
METHODS. IL-18 detection was performed by using 5-bromo-4-chloro-3-indoyl-b
eta -D-galactopyranoside (X-Gal) staining on frozen sections of eps from mi
ce (129/CD1, DBA1, and Balb/c), either of normal phenotype (+/+) or of defi
ciency (+/-, -/-) in the IL-18 gene which had been replaced by introduced g
enes including LacZ under the control of an IL-18 promotor. Severity of EAU
was assessed in DBA1 and 129/CD1 wild-type (va) or IL-18 knockout (KO) mic
e after immunization with the uveitogenic antigen: interphotoreceptor retin
al binding protein (IRBP) peptide 161-180. Lymphocyte proliferation and cyt
okine production were also measured in WT and IL-18 KO DBA1 mice 15 days af
ter immunization.
RESULTS. IL-18 is constitutively expressed in the epithelial cells in iris,
ciliary body, and retina. EAU-resistant mice (129/CD1) with an IL-18(-/-)
phenotype remained resistant after immunization with IRBP peptide (P161-180
). However, EAU-susceptible mice (DBA1) exhibited disease with similar hist
ologic characteristics, despite a generalized reduction of interferon (IFN)
-gamma and tumor necrosis factor (TNF)-alpha on an IL-18(-/-) phenotype. DB
A1 IL-18(-/-) also demonstrated reduced IL-10 production.
Conclusions. The IL-18 gene is not necessary for the initiation or pathogen
esis of EAU induced by IRBP peptide 161-180. IL-18 is expressed in the epit
helial cells in iris, ciliary body, and retina in the eyes, but its role in
the eye remains undetermined.